BioVie Inc.: 10-K filed 2020-08-06
What BioVie Inc. reported in its annual report filed 2020-08-06 (fiscal FY 2020): 28 published measures, 56 facts as tagged in accession 0001520138-20-000356.
This filing
- Form
- 10-K (annual report)
- Filed
- 2020-08-06
- Fiscal period
- fiscal FY 2020
- Accession
- 0001520138-20-000356 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BioVie Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 2,083,917 | USD | |
| At 2019-06-30 | 2,574,387 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 23,582,553 | USD | |
| At 2019-06-30 | 443,480 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | -21,498,636 | USD | |
| At 2019-06-30 | 2,130,907 | USD |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2020-06-30 | -1,628,228 | USD | 366 |
| 2018-07-01 to 2019-06-30 | -2,501,577 | USD | 365 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2020-06-30 | 1,325,500 | USD | 366 |
| 2018-07-01 to 2019-06-30 | 2,795,700 | USD | 365 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | -41,037,898 | USD | |
| At 2019-06-30 | -7,262,072 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2020-06-30 | 4,929,497 | shares | 366 |
| 2018-07-01 to 2019-06-30 | 2,539,611 | shares | 365 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2020-06-30 | 4,929,497 | shares | 366 |
| 2018-07-01 to 2019-06-30 | 2,539,611 | shares | 365 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2020-06-30 | -6.85 | USD/shares | 366 |
| 2018-07-01 to 2019-06-30 | -0.98 | USD/shares | 365 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2020-06-30 | -6.85 | USD/shares | 366 |
| 2018-07-01 to 2019-06-30 | -0.98 | USD/shares | 365 |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2020-06-30 | 24,846 | USD | 366 |
| 2018-07-01 to 2019-06-30 | 64,860 | USD | 365 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2020-06-30 | -2,692,888 | USD | 366 |
| 2018-07-01 to 2019-06-30 | -2,496,573 | USD | 365 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 412,980 | USD | |
| At 2019-06-30 | 674,073 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2020-06-30 | 4,772,429 | USD | 366 |
| 2018-07-01 to 2019-06-30 | 273 | USD | 365 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 23,520,053 | USD | |
| At 2019-06-30 | 443,480 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 1,259,206 | USD | |
| At 2019-06-30 | 443,480 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 345,711 | USD | |
| At 2019-06-30 | 345,711 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 1,325,226 | USD | |
| At 2019-06-30 | 1,554,603 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2020-06-30 | 2,692,888 | USD | 366 |
| 2018-07-01 to 2019-06-30 | 2,496,573 | USD | 365 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2020-06-30 | 1,312,930 | USD | 366 |
| 2018-07-01 to 2019-06-30 | 1,259,096 | USD | 365 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2020-06-30 | 1,150,581 | USD | 366 |
| 2018-07-01 to 2019-06-30 | 1,008,100 | USD | 365 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 5,204,392 | shares | |
| At 2019-06-30 | 4,058,724 | shares |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | -21,498,636 | USD | |
| At 2019-06-30 | 2,130,907 | USD | |
| At 2018-06-30 | 111,199 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 1,325,226 | USD | |
| At 2019-06-30 | 1,554,603 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2020-06-30 | -16,676,768 | USD | 366 |
| 2018-07-01 to 2019-06-30 | -2,444,287 | USD | 365 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2020-06-30 | 229,377 | USD | 366 |
| 2018-07-01 to 2019-06-30 | 229,377 | USD | 365 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2020-06-30 | 3,093 | USD | 366 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2020-06-30 | 815,726 | USD | 366 |
| 2018-07-01 to 2019-06-30 | -117,777 | USD | 365 |
Inspect the source
- Entity
- BioVie Inc. / CIK 0001580149
- Captured
- 2026-09-20T09:22:31.582Z
- SEC response SHA-256
f572a001c48a2e876d70fd7a358ae1e5a994eab357401042d4f8aa6551a9ee85
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001580149.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))